These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27659555)

  • 1. Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole.
    Hatalova H; Radostova D; Pistikova A; Vales K; Stuchlik A
    Behav Brain Res; 2017 Jan; 317():210-217. PubMed ID: 27659555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder.
    Janikova M; Brozka H; Radostova D; Svoboda J; Stuchlik A
    Physiol Behav; 2019 May; 204():241-247. PubMed ID: 30826389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial reversal learning in chronically sensitized rats and in undrugged sensitized rats with dopamine d2-like receptor agonist quinpirole.
    Hatalova H; Radostova D; Pistikova A; Vales K; Stuchlik A
    Front Behav Neurosci; 2014; 8():122. PubMed ID: 24782730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD.
    Eagle DM; Noschang C; d'Angelo LS; Noble CA; Day JO; Dongelmans ML; Theobald DE; Mar AC; Urcelay GP; Morein-Zamir S; Robbins TW
    Behav Brain Res; 2014 May; 264(100):207-29. PubMed ID: 24406720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder.
    Tizabi Y; Louis VA; Taylor CT; Waxman D; Culver KE; Szechtman H
    Biol Psychiatry; 2002 Jan; 51(2):164-71. PubMed ID: 11822995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model.
    Szechtman H; Culver K; Eilam D
    Pol J Pharmacol; 1999; 51(1):55-61. PubMed ID: 10389145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
    Perreault ML; Seeman P; Szechtman H
    Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethological approach to the form of compulsive rituals.
    Eilam D; Szechtman H
    CNS Spectr; 2005 Mar; 10(3):191-202. PubMed ID: 15744221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD).
    Szechtman H; Sulis W; Eilam D
    Behav Neurosci; 1998 Dec; 112(6):1475-85. PubMed ID: 9926830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.
    Sesia T; Bizup B; Grace AA
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1295-307. PubMed ID: 23360787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective serotonin reuptake inhibitor ameliorates obsessive-compulsive disorder-like perseverative behavior by attenuating 5-HT
    Hatakama H; Asaoka N; Nagayasu K; Shirakawa H; Kaneko S
    Neuropharmacology; 2022 Mar; 206():108926. PubMed ID: 34921828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
    De Carolis L; Schepisi C; Milella MS; Nencini P
    Psychopharmacology (Berl); 2011 Dec; 218(4):749-59. PubMed ID: 21660444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasticity-Related Activity in the Hippocampus, Anterior Cingulate, Orbitofrontal, and Prefrontal Cortex Following a Repeated Treatment with D
    Brozka H; Alexova D; Radostova D; Janikova M; Krajcovic B; Kubík Š; Svoboda J; Stuchlik A
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Sharma R; Taji L; Cheon P; Peel J; Kirk A; Szechtman H
    Psychopharmacology (Berl); 2014 Sep; 231(18):3707-18. PubMed ID: 24682503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit.
    Alkhatib AH; Dvorkin-Gheva A; Szechtman H
    Behav Pharmacol; 2013 Feb; 24(1):65-73. PubMed ID: 23249525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Johnson E; Wong M; Szechtman H
    Behav Brain Res; 2015 Feb; 279():211-7. PubMed ID: 25449840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
    Nakamae T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Graham D; Amodeo S; Cheon P; Kirk A; Peel J; Taji L; Szechtman H
    Psychopharmacology (Berl); 2013 May; 227(2):277-85. PubMed ID: 23354534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
    de Oliveira MVS; de Barros PMF; de Mathis MA; Boavista R; Chacon P; Echevarria MAN; Ferrão YA; Vattimo EFQ; Lopes AC; Torres AR; Diniz JB; Fontenelle LF; Rosário MCD; Shavitt RG; Miguel EC; da Silva RMF; Costa DLDC
    Braz J Psychiatry; 2023 May; 45(2):146-161. PubMed ID: 36749887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.